{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:45:39Z","timestamp":1789469139236,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Louisiana State University in Shreveport"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07132-8","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:44:18Z","timestamp":1781545458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic lineage evolution in hematologic malignancies: a case report of B-ALL Progressing to CMML and AML"],"prefix":"10.1007","volume":"105","author":[{"given":"Sheikh","family":"Abdullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Marrero","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Jashwanth","family":"Gaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Amalraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faryal","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Ramadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"Suppl 1","key":"7132_CR1","first-page":"12","volume":"44","author":"J Kurzer","year":"2022","unstructured":"Kurzer J, Weinberg OK (2022) To B or not to B? A review of lineage-switched acute leukemias. Int J Lab Hematol 44(Suppl 1):12\u201319","journal-title":"Int J Lab Hematol"},{"key":"7132_CR2","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1182\/blood-2015-08-665547","volume":"127","author":"R Gardner","year":"2016","unstructured":"Gardner R, Wu D, Cherian S et al (2016) <article-title update=\"added\">Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy. Blood 127:2406\u20132410","journal-title":"Blood"},{"key":"7132_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1182\/blood.2024026655","volume":"146","author":"SK Silbert","year":"2025","unstructured":"Silbert SK, Rankin AW, Hoang CN et al (2025) Project EVOLVE: an international analysis of post-immunotherapy lineage switch, an emergent form of relapse in leukemia. Blood 146:437\u2013455","journal-title":"Blood"},{"key":"7132_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12308-023-00539-6","volume":"16","author":"JR Wu","year":"2023","unstructured":"Wu JR, Shih LY, Li CC et al (2023) Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy. J Hematop 16:103\u2013109","journal-title":"J Hematop"},{"key":"7132_CR5","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1080\/10428194.2024.2351194","volume":"65","author":"K Be\u0142dzi\u0144ska-G\u0105dek","year":"2024","unstructured":"Be\u0142dzi\u0144ska-G\u0105dek K, Zarzycka E, Pastuszak K et al (2024) Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia. Leuk Lymphoma 65:1292\u20131302","journal-title":"Leuk Lymphoma"},{"key":"7132_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10147-009-0007-3","volume":"15","author":"O Imataki","year":"2010","unstructured":"Imataki O, Uemura M, Uchida S et al (2010) Lineage switch from precursor B-cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse. Int J Clin Oncol 15:112\u2013115","journal-title":"Int J Clin Oncol"},{"key":"7132_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/ajcp\/aqx055","volume":"148","author":"B Wu","year":"2017","unstructured":"Wu B, Li L, Zhang W et al (2017) Lineage switch between B-lymphoblastic leukemia and acute myeloid leukemia intermediated by \u201coccult\u201d myelodysplastic neoplasm: two cases of adult patients with evidence of genomic instability and clonal selection by chemotherapy. Am J Clin Pathol 148:136\u2013147","journal-title":"Am J Clin Pathol"},{"key":"7132_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9040152","volume":"9","author":"MY Wu","year":"2019","unstructured":"Wu MY, Kao WY, Chan CY et al (2019) Spontaneous splenic rupture as a rare initial presentation in an acute lymphoblastic leukemia patient. Diagnostics (Basel) 9:152","journal-title":"Diagnostics (Basel)"},{"key":"7132_CR9","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/leu.2014.125","volume":"28","author":"MM Patnaik","year":"2014","unstructured":"Patnaik MM, Itzykson R, Lasho TL et al (2014) ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients. Leukemia 28:2206\u20132212","journal-title":"Leukemia"},{"key":"7132_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.799982","volume":"12","author":"R Takeda","year":"2022","unstructured":"Takeda R, Yokoyama K, Fukuyama T et al (2022) Repeated lineage switches in an elderly case of refractory B-cell acute lymphoblastic leukemia with MLL gene amplification: a case report and literature review. Front Oncol 12:799982","journal-title":"Front Oncol"},{"key":"7132_CR11","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36:1703\u20131719","journal-title":"Leukemia"},{"key":"7132_CR12","doi-asserted-by":"publisher","first-page":"85937","DOI":"10.18632\/oncotarget.13262","volume":"7","author":"S Bertoli","year":"2016","unstructured":"Bertoli S, Tavitian S, Huynh A et al (2016) Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies: clinical characteristics and genomic landscape. Oncotarget 7:85937\u201385947","journal-title":"Oncotarget"},{"key":"7132_CR13","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1182\/bloodadvances.2018018093","volume":"2","author":"M W\u00f6lfl","year":"2018","unstructured":"W\u00f6lfl M, Rasche M, Eyrich M et al (2018) Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch. Blood Adv 2:1382\u20131385","journal-title":"Blood Adv"},{"key":"7132_CR14","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2021013626","volume":"138","author":"M Heuser","year":"2021","unstructured":"Heuser M, Freeman SD, Ossenkoppele GJ et al (2021) 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party. Blood 138:2753\u20132767","journal-title":"Blood"},{"key":"7132_CR15","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1182\/bloodadvances.2022009480","volume":"7","author":"BM Lee","year":"2023","unstructured":"Lee BM, Summers C, Chisholm KM et al (2023) Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy. Blood Adv 7:2825\u20132830","journal-title":"Blood Adv"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07132-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:42:47Z","timestamp":1789465367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07132-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":15,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["7132"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07132-8","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the institutional review board of Louisiana State University Health Sciences Center, Shreveport. Written informed consent was obtained from the patient for the use of clinical and molecular data, including publication of de-identified clinical details and laboratory findings.","order":1,"name":"Ethics","label":"Ethics and consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"390"}}